Paul Cornes

1.9k total citations
48 papers, 1.3k citations indexed

About

Paul Cornes is a scholar working on Oncology, Economics and Econometrics and Immunology. According to data from OpenAlex, Paul Cornes has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Economics and Econometrics and 12 papers in Immunology. Recurrent topics in Paul Cornes's work include Biosimilars and Bioanalytical Methods (12 papers), Neutropenia and Cancer Infections (10 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Paul Cornes is often cited by papers focused on Biosimilars and Bioanalytical Methods (12 papers), Neutropenia and Cancer Infections (10 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Paul Cornes collaborates with scholars based in United Kingdom, Switzerland and United States. Paul Cornes's co-authors include Matti Aapro, Nick Johnson, Ivo Abraham, J.P. Glees, Hoda Al‐Booz, Chris Williams, Tracie Miles, Andrew Bryant, Thomas Högberg and Josef S Smolen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Paul Cornes

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Cornes United Kingdom 22 445 320 264 259 195 48 1.3k
Andrea Giannini Italy 30 330 0.7× 102 0.3× 706 2.7× 509 2.0× 115 0.6× 109 1.8k
George Papaxoinis Greece 25 960 2.2× 105 0.3× 164 0.6× 449 1.7× 381 2.0× 99 1.9k
Barbara Schmalfeldt Germany 23 884 2.0× 156 0.5× 481 1.8× 719 2.8× 189 1.0× 92 2.1k
Thomas L. Jang United States 22 579 1.3× 313 1.0× 74 0.3× 637 2.5× 1.4k 7.3× 120 2.5k
Giorgia Perniola Italy 30 474 1.1× 190 0.6× 1.1k 4.2× 720 2.8× 146 0.7× 144 2.6k
Christian Doehn Germany 20 459 1.0× 242 0.8× 75 0.3× 496 1.9× 775 4.0× 138 1.6k
P. Harper United Kingdom 18 551 1.2× 50 0.2× 56 0.2× 154 0.6× 278 1.4× 43 1.1k
Angela Musella Italy 23 376 0.8× 75 0.2× 546 2.1× 327 1.3× 163 0.8× 75 1.5k
Howard G. Muntz United States 21 392 0.9× 80 0.3× 1.2k 4.6× 567 2.2× 335 1.7× 50 2.4k
Iuliana Shapira United States 20 787 1.8× 176 0.6× 12 0.0× 141 0.5× 247 1.3× 53 1.6k

Countries citing papers authored by Paul Cornes

Since Specialization
Citations

This map shows the geographic impact of Paul Cornes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Cornes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Cornes more than expected).

Fields of papers citing papers by Paul Cornes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Cornes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Cornes. The network helps show where Paul Cornes may publish in the future.

Co-authorship network of co-authors of Paul Cornes

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Cornes. A scholar is included among the top collaborators of Paul Cornes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Cornes. Paul Cornes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kvien, Tore K, Neil Betteridge, Silvio Danese, et al.. (2025). Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings. BioDrugs. 39(4). 537–553.
2.
Mestre-Ferrándiz, Jorge, Marcin Czech, Josef S Smolen, et al.. (2024). Leveraging the holistic benefits of biosimilars in Europe – part 2: how payers can safeguard the future of a healthy biosimilar market environment. Expert Review of Pharmacoeconomics & Outcomes Research. 24(4). 509–519. 2 indexed citations
3.
Aapro, Matti, Stephen Chaplin, Paul Cornes, et al.. (2023). Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer. Supportive Care in Cancer. 31(10). 581–581. 4 indexed citations
4.
5.
Aapro, Matti, Gary H. Lyman, Carsten Bokemeyer, et al.. (2021). Supportive care in patients with cancer during the COVID-19 pandemic. ESMO Open. 6(1). 100038–100038. 26 indexed citations
6.
Jazieh, Abdul Rahman, Elena Pizzo, László Gulàcsi, et al.. (2019). Implementation of Country-Wide Pharmacoeconomic Principles in Cancer Care in Developing Countries: Expert-Based Recommendations. SHILAP Revista de lepidopterología. 2(4). 109–114. 2 indexed citations
7.
Cornes, Paul & Matti Aapro. (2018). The Impact of Biosimilars in Supportive Care in Cancer. European Oncology & Haematology. 14(1). 20–20. 7 indexed citations
8.
Cornes, Paul, et al.. (2014). Monitoring of Liver Function Tests in the First 12 Weeks of Abiraterone Acetate Treatment. Clinical Oncology. 26(2). e7–e7.
9.
Cornes, Paul, et al.. (2013). Vaginal vault brachytherapy in endometrial cancer: verifying target coverage with image-guided applicator placement. British Journal of Radiology. 86(1023). 20120428–20120428. 18 indexed citations
10.
Dingermann, Theo, et al.. (2012). Biosimilar monoclonal antibodies: the next frontier. A summary report from a symposium held at EAHP 2012. European Journal of Hospital Pharmacy. 19(3). 315–317.
11.
Johnson, Nick, Toni P. Miles, & Paul Cornes. (2010). Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. BJOG An International Journal of Obstetrics & Gynaecology. 117(5). 522–531. 28 indexed citations
12.
Lloyd, Andrew, et al.. (2008). Health State Utility Scores for Cancer-Related Anemia through Societal and Patient Valuations. Value in Health. 11(7). 1178–1185. 30 indexed citations
13.
14.
Kong, Anthony, Nick Johnson, Paul Cornes, et al.. (2007). Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database of Systematic Reviews. CD003916–CD003916. 30 indexed citations
15.
Johnson, Nick & Paul Cornes. (2007). Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta‐analysis. BJOG An International Journal of Obstetrics & Gynaecology. 114(11). 1313–1320. 67 indexed citations
16.
Al‐Booz, Hoda, et al.. (2006). Sigmoid colon is an unexpected organ at risk in brachytherapy for cervix cancer.. PubMed. 18(2). 156–60. 12 indexed citations
17.
Österborg, Anders, Matti Aapro, Paul Cornes, et al.. (2006). Preclinical studies of erythropoietin receptor expression in tumour cells: Impact on clinical use of erythropoietic proteins to correct cancer-related anaemia. European Journal of Cancer. 43(3). 510–519. 59 indexed citations
18.
Ragoowansi, Raj, B.W.E.M. Powell, A.L.H. Moss, Paul Cornes, & J.P. Glees. (2001). Ear-lobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. British Journal of Plastic Surgery. 54(6). 504–508. 49 indexed citations
19.
Cooper, Colin S. & Paul Cornes. (1997). Molecular genetics of soft tissue sarcomas. Cancer treatment and research. 91. 31–50. 3 indexed citations
20.
Horwich, A., Caroline Wilson, Paul Cornes, J. Gildersleve, & David P. Dearnaley. (1993). Increasing the Dose Intensity ofChemotherapy in Poor-PrognosisMetastatic Non-Seminoma. European Urology. 23(1). 219–222. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Giannini Breakdown of academic impact, for papers by George Papaxoinis Breakdown of academic impact, for papers by Barbara Schmalfeldt Breakdown of academic impact, for papers by Thomas L. Jang Breakdown of academic impact, for papers by Giorgia Perniola Breakdown of academic impact, for papers by Christian Doehn Breakdown of academic impact, for papers by P. Harper Breakdown of academic impact, for papers by Angela Musella Breakdown of academic impact, for papers by Howard G. Muntz Breakdown of academic impact, for papers by Iuliana Shapira
Rankless by CCL
2026